Studying the efficacy of low-dose colchicine on clinical outcomes of patients with STEMI: a randomized controlled trial

Abstract Background Numerous studies have underscored the essential role of inflammation across all stages of atherosclerosis. While various anti-inflammatory interventions have been implemented to mitigate inflammation-induced injuries, outcomes have been conflicting. Given the essential role of in...

Full description

Bibliographic Details
Published in:	The Egyptian Heart Journal
Main Authors:	Mojtaba Yousefzadeh, Ali Khosrobeigi, Ayoub Salehi
Format:	Article
Language:	English
Published:	SpringerOpen 2024-07-01
Subjects:	Colchicine STEMI Inflammation
Online Access:	https://doi.org/10.1186/s43044-024-00515-0

Similar Items

Role of Colchicine in Reducing Reperfusion Injury in STEMI Patients Who Undergo Primary Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Birry Karim, et al.
Published: (2025-04-01)

Role of Colchicine in Reducing Reperfusion Injury in STEMI Patients Who Undergo Primary Percutaneous Coronary Intervention: A Randomized Clinical Trial
by: Birry Karim, et al.
Published: (2025-01-01)

What is the lowest lethal dose of colchicine?
by: Vanyo Mitev
Published: (2023-03-01)

Effect of Colchicine in reducing MMP-9, NOX2, and TGF- β1 after myocardial infarction
by: Suryono Suryono, et al.
Published: (2023-09-01)

Colchicine for gout
by: M. S. Eliseev, et al.
Published: (2021-08-01)

Implementation of a Regional STEMI Network in North Cairo (Egypt): Impact on The Management and Outcome of STEMI Patients
by: Sameh M. Shaheen, et al.
Published: (2023-01-01)

Efficacy and safety of long-term administration of various doses of colchicine in patients with gout
by: M. S. Eliseev, et al.
Published: (2025-05-01)

Colchicine in Patients With Coronary Artery Disease: A Systematic Review and Meta‐Analysis of Randomized Trials
by: Thomas Kofler, et al.
Published: (2021-08-01)

High Colchicine Doses Are Really Silver Bullets Against COVID-19
by: Mitev V.
Published: (2024-12-01)

Colchicine: Repositioning an “ancient” medicine in the 21st century
by: E. L. Nasonov, et al.
Published: (2018-06-01)

Clinical outcomes of patients undergoing percutaneous coronary intervention treated with colchicine
by: César E. Soria Jiménez, et al.
Published: (2023-05-01)

Effects of Colchicine in a Rat Model of Diet-Induced Hyperlipidemia
by: Denisa-Mădălina Zălar, et al.
Published: (2022-01-01)

Low‐Dose Colchicine Ameliorates Doxorubicin Cardiotoxicity Via Promoting Autolysosome Degradation
by: Ying Peng, et al.
Published: (2024-05-01)

Colchicine and diabetes in patients with chronic coronary artery disease: insights from the LoDoCo2 randomized controlled trial
by: Niekbachsh Mohammadnia, et al.
Published: (2023-10-01)

Repurposing colchicine’s journey in view of drug-to-drug interactions. A review
by: Dimitrios A. Vrachatis, et al.
Published: (2021-01-01)

Colchicine: Repositioning an “ancient” medicine in the 21<sup>st</sup> century
by: E. L. Nasonov, et al.
Published: (2024-11-01)

Silent STEMI
by: Sirovica Zsuzsanna, et al.
Published: (2014-01-01)

Proteomic evaluation of the thrombosis-inflammation interplay in STEMI with MVO
by: Yu Qi, et al.
Published: (2025-04-01)

Comparison of the efficacy and safety of tocilizumab for colchicine-resistant or colchicine-intolerant familial Mediterranean fever: study protocol for an investigator-initiated, multicenter, randomized, double-blind, placebo-controlled trial
by: Tomohiro Koga, et al.
Published: (2018-12-01)

The efficacy of colchicine and dapsone combination therapy in relapsed immune thrombocytopenia
by: Thanawat Rattanathammethee, et al.
Published: (2017-02-01)

Left ventricular apex rupture in STEMI
by: Amr Mohamed
Published: (2021-07-01)

Rhabdomyolysis induced by co-administration of fluvastatin and colchicine
by: Filippo M. Sarullo, et al.
Published: (2015-12-01)

Efficacy and Safety of Anakinra in Colchicine-Resistant or -Intolerant Familial Mediterranean Fever: A Single-Center Real-Life Experience
by: Tuğba Ocak, et al.
Published: (2025-04-01)

Editorial: Role of colchicine in atherosclerosis
by: Ashish Misra, et al.
Published: (2024-11-01)

Effects of colchicine on cardiac functions
by: Yusuf Ziya Şener, et al.
Published: (2019-11-01)

Colchicine protects rat skeletal muscle from ischemia/reperfusion injury by suppressing oxidative stress and inflammation
by: Liangrong Wang, et al.
Published: (2016-06-01)

Colchicine sebagai Terapi Spesifik pada Gout Arthritis Akut
by: Fahrul Amri
Published: (2010-08-01)

A novel colchicine-myricetin heterozygous molecule: design, synthesis, and effective evaluations on the pathological models of acute lung injury in vitro and in vivo
by: Zhiyue Li, et al.
Published: (2023-06-01)

Possible ameliorative effect of colchicine on the prevention of cytokine storm and its associated hyper-inflammation in patients with COVID-19
by: Bijan Keikhaei, et al.
Published: (2020-01-01)

Evaluation of Pentoxifylline and Colchicine Administration on Clinical Outcomes of Hospitalized Patients with COVID-19
by: AR Eghbali, et al.
Published: (2023-03-01)

Efficacy of Colchicine in Improving Outcomes in Coronary Artery Disease: A Systematic Review and Meta-Analysis
by: Nahush Bansal, et al.
Published: (2025-06-01)

Improving STEMI Management Internationally
by: Cesar J. Herrera, MD, et al.
Published: (2025-01-01)

NEW POSSIBILITIES IN THE TREATMENT OF CARDIOVASCULAR DISEASE USING COLCHICINE
by: M. T. Vatutin, et al.
Published: (2016-06-01)

Colchicine for the treatment of COVID-19: short path from theory to practice
by: M. S. Eliseev, et al.
Published: (2022-07-01)

Colchicine Protects against Ethanol-Induced Senescence and Senescence-Associated Secretory Phenotype in Endothelial Cells
by: Huakang Zhou, et al.
Published: (2023-04-01)

Colchicine in Cardiac Surgery: The COCS Randomized Clinical Trial
by: Vladimir Shvartz, et al.
Published: (2022-10-01)

Colchicine in atrial fibrillation: are old trees in bloom?
by: Yujia Zhan, et al.
Published: (2023-10-01)

Distance-related Differences in Critical Times, Protocol Activation and Mortality in a Regional STEMI Network
by: Bajka Balázs, et al.
Published: (2016-09-01)

Epidemiological profile and clinical outcomes of very young (<35 years) and young (35–50 years) patients with STEMI: Insights from the NORIN STEMI registry
by: Mohit D. Gupta, et al.
Published: (2024-03-01)

Delivery Strategies for Colchicine as a Critical Dose Drug: Reducing Toxicity and Enhancing Efficacy
by: Yaran Lei, et al.
Published: (2024-02-01)